Literature DB >> 30796354

The inhibitory mechanism of aurintricarboxylic acid targeting serine/threonine phosphatase Stp1 in Staphylococcus aureus: insights from molecular dynamics simulations.

Ting-Ting Liu1,2, Teng Yang3, Mei-Na Gao1,2, Kai-Xian Chen1,2, Song Yang4, Kun-Qian Yu5,6, Hua-Liang Jiang1,2,7.   

Abstract

Serine/threonine phosphatase (Stp1) is a member of the bacterial Mg2+- or Mn2+- dependent protein phosphatase/protein phosphatase 2C family, which is involved in the regulation of Staphylococcus aureus virulence. Aurintricarboxylic acid (ATA) is a known Stp1 inhibitor with an IC50 of 1.03 μM, but its inhibitory mechanism has not been elucidated in detail because the Stp1-ATA cocrystal structure has not been determined thus far. In this study, we performed 400 ns molecular dynamics (MD) simulations of the apo-Stp1 and Stp1-ATA complex models. During MD simulations, the flap subdomain of the Stp1-ATA complex experienced a clear conformational transition from an open state to a closed state, whereas the flap domain of apo-Stp1 changed from an open state to a semi-open state. In the Stp1-ATA complex model, the hydrogen bond (H-bond) between D137 and N142 disappeared, whereas critical H-bond interactions were formed between Q160 and H13, Q160/R161 and ATA, as well as N162 and D198. Finally, four residues (D137, N142, Q160, and R161) in Stp1 were mutated to alanine and the mutant enzymes were assessed using phosphate enzyme activity assays, which confirmed their important roles in maintaining Stp1 activity. This study indicated the inhibitory mechanism of ATA targeting Stp1 using MD simulations and sheds light on the future design of allosteric Stp1 inhibitors.

Entities:  

Keywords:  Staphylococcus aureus; antimicrobial resistance; aurintricarboxylic acid; flap subdomain; molecular dynamics simulations; serine/threonine phosphatase

Mesh:

Substances:

Year:  2019        PMID: 30796354      PMCID: PMC6786342          DOI: 10.1038/s41401-019-0216-x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  53 in total

1.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

Review 2.  Targeting virulence: a new paradigm for antimicrobial therapy.

Authors:  Anne E Clatworthy; Emily Pierson; Deborah T Hung
Journal:  Nat Chem Biol       Date:  2007-09       Impact factor: 15.040

3.  Microbiology. Sources of antimicrobial resistance.

Authors:  Mark E J Woolhouse; Melissa J Ward
Journal:  Science       Date:  2013-09-12       Impact factor: 47.728

4.  Infectious disease. A return to the pre-antimicrobial era?

Authors:  Stephen Baker
Journal:  Science       Date:  2015-03-06       Impact factor: 47.728

5.  State-of-the-art technology in modern computer-aided drug design.

Authors:  Georgios A Dalkas; Dimitrios Vlachakis; Dimosthenis Tsagkrasoulis; Anastasia Kastania; Sophia Kossida
Journal:  Brief Bioinform       Date:  2012-11-12       Impact factor: 11.622

6.  Modulation of abscisic acid signaling in vivo by an engineered receptor-insensitive protein phosphatase type 2C allele.

Authors:  Florine Dupeux; Regina Antoni; Katja Betz; Julia Santiago; Miguel Gonzalez-Guzman; Lesia Rodriguez; Silvia Rubio; Sang-Youl Park; Sean R Cutler; Pedro L Rodriguez; José A Márquez
Journal:  Plant Physiol       Date:  2011-02-28       Impact factor: 8.340

7.  Stabilization of microtubules by taxane diterpenoids: insight from docking and MD simulations.

Authors:  Umesh Yadava; Hariom Gupta; Mihir Roychoudhury
Journal:  J Biol Phys       Date:  2014-12-27       Impact factor: 1.365

8.  Clustal Omega for making accurate alignments of many protein sequences.

Authors:  Fabian Sievers; Desmond G Higgins
Journal:  Protein Sci       Date:  2017-10-30       Impact factor: 6.725

9.  Structure of the phosphatase domain of the cell fate determinant SpoIIE from Bacillus subtilis.

Authors:  Vladimir M Levdikov; Elena V Blagova; Andrea E Rawlings; Katie Jameson; James Tunaley; Darren J Hart; Imrich Barak; Anthony J Wilkinson
Journal:  J Mol Biol       Date:  2011-11-15       Impact factor: 5.469

10.  MAE4, an eLtaS monoclonal antibody, blocks Staphylococcus aureus virulence.

Authors:  Yu Liu; Jiannan Feng; Qiang Lu; Xin Zhang; Yaping Gao; Jun Yan; Chunhua Mu; Yan Hei; Ming Lv; Gencheng Han; Guojiang Chen; Peng Jin; Weiguo Hu; Beifen Shen; Guang Yang
Journal:  Sci Rep       Date:  2015-11-24       Impact factor: 4.379

View more
  1 in total

1.  Fgd5 is a Rac1-specific Rho GEF that is selectively inhibited by aurintricarboxylic acid.

Authors:  Sally Park; Yitian Guo; Judeah Negre; Jordane Preto; Cameron C Smithers; Abul Kalam Azad; Michael Overduin; Allan G Murray; Gary Eitzen
Journal:  Small GTPases       Date:  2019-10-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.